Health ❯Healthcare

Obesity

Dieting Obesity Prevention Emerging Markets Clinical Studies Obesity Management Addiction Insurance Premiums Patient Care Weight Loss Journeys Global Health

Bariatric Surgery Surpasses GLP-1 Drugs in Real-World Weight Loss

New findings show surgery delivers more durable weight loss with lower psychiatric risks compared to weekly semaglutide or tirzepatide injections.

High BMI and Black Patients Face Greater Minor Complication Risks After Bariatric Surgery

Real-World GLP-1 Therapy Yields Lower Weight Loss, Spurs Tetra-Receptor Drug Research

Mounjaro Delivers Rapid Weight Loss as UK Health Officials Warn of Serious Risks

Health Secretary Urges Faster NHS Rollout of Weight-Loss Injections

Waist-to-Height Ratio Found to Strongly Predict Heart Failure Risk

Brain Neurons Found to Drive Type 2 Diabetes, Independent of Obesity

Oxford Study Reveals Rapid Weight Regain After Stopping GLP-1 Drugs

Tirzepatide Outperforms Semaglutide in Weight-Loss Trial

GLP-1 Drugs Found to Cut Alcohol Consumption and Improve Mental Health

Weight Management Revolution: GLP-1 Drugs Dominate as Pills Emerge

UK Government Proposes Pharmacy Access for Weight-Loss Jabs Amid Rising Demand

UK to Trial Pharmacy-Based NHS Weight-Loss Jab Prescriptions

WHO to Endorse GLP-1 Weight-Loss Drugs, Calls for Global Access

Diabetes Drug Metformin Reduces Knee Pain in Osteoarthritis Patients, Study Finds

Novo Nordisk Seeks FDA Approval as Eli Lilly's Weight-Loss Pill Advances

Eli Lilly's Oral GLP-1 Pill Demonstrates Success in Phase 3 Trials

Eli Lilly's Mounjaro Launches in India, Targeting Obesity and Diabetes

Eli Lilly Launches Mounjaro in India to Address Obesity and Diabetes

Taxpayer-Funded Weight-Loss Drugs Face Scrutiny Over High Prices